Dr. Hsueh received his Ph.D. in Neuroscience from the Taipei Medical University (Taiwan) in 2019, working in the preclinical research laboratory of Dr. Yung-Hsiao Chiang. During the doctoral training, he was focusing on novel treatments for neurodegeneration diseases using animal models. He had assessed the neuroprotective effects of voluntary exercise in Parkinson’s disease (PD) rat model and small molecules with translatable potential to treat traumatic brain injury (TBI) by behavioral test assessments, immunostaining, as well as brain tissue processing and analysis. In 2017, Dr. Hsueh received the award for graduate students to study abroad in a program sponsored by the Ministry of Science and Technology in Taiwan, and he was honored to have the training under Dr. Barry Hoffer and Dr. Agnes Luo at Case Western Reserve University in Cleveland for two years. In 2019, Dr. Hsueh joined the Laboratory of Drug Design and Development Section (DDDS) under the supervision of Dr. Nigel Greig. He continues to focus on treatment effects of novel compounds in TBI animal model, using broader assessments to evaluate the behavioral changes, levels of inflammation, and disease outcomes.